SCHEMBL7001864

SCHEMBL7001864

COc1cccc2c1c(O)c(C(=O)N(C)c1ccccc1F)c(=O)n2C

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.66
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
PGR P06401 1/20 0.47
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
NLRP3 Q96P20 1/20 0.39
ALDH1A1 P00352 4/20 0.39
POLB P06746 3/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PABPC1 P11940 1/20 0.39
RORC P51449 1/20 0.38
MAPT P10636 1/20 0.38
TSHR P16473 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KDM4E B2RXH2 1/20 0.38
TP53 P04637 1/20 0.37
MAP3K5 Q99683 1/20 0.36
HIF1A Q16665 1/20 0.36
BRPF1 P55201 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5163897 0.90 HDAC4 (0.64) HDAC4MEN1KMT2APGRALDH1A1
SCHEMBL5163474 0.90 HDAC4 (0.64) HDAC4MEN1KMT2APGRPOLB
SCHEMBL14311955 0.87 HDAC4 (0.71) HDAC4MEN1KMT2APGRALDH1A1
SCHEMBL6994317 0.85 HDAC4 (0.77) HDAC4MEN1KMT2APGRALDH1A1
SCHEMBL19398184 0.82 HDAC4 (0.79) HDAC4MEN1KMT2APGRALDH1A1
SCHEMBL14312102 0.81 HDAC4 (0.65) HDAC4MEN1KMT2APGRALDH1A1
SCHEMBL7002185 0.80 HDAC4 (0.76) HDAC4MEN1KMT2APGRALDH1A1
Tasquinimod SCHEMBL4476895 0.80 HDAC4 (1.00) HDAC4MEN1KMT2APGRPOLB
Tasquinimod SCHEMBL29362522 0.80 HDAC4 (1.00) HDAC4MEN1KMT2APGRPOLB
SCHEMBL7537746 0.79 HDAC4 (0.54) HDAC4MEN1KMT2AALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1095021-B1 QUINOLINE DERIVATIVES ACTIVE BIOTECH AB (SE) 2003-09-17 EP disclosed
US-6593343-B2 Quinoline derivatives ACTIVE BIOTECH AB (SE) 2003-07-15 US disclosed
US-20020173519-A1 Quinoline derivatives ACTIVE BIOTECH AB (SE) 2002-11-21 US disclosed
US-6133285-A 1-METHYL-2-OXO-3-N-PHENYL-N-METHYLAMINOCARBONYL-4-HYDROXY-1,2 -DIHYDRO-QUINOLINES; AUTOIMMUNE DISEASE AND PATHOLOGICAL INFLAMMATION, E.G., ASTHMA, ATHEROSCLEROSIS, STROKE AND ALZHEIMER'S DISEASE AND, ESPECIALLY, MULTIPLE SCLEROSIS ACTIVE BIOTECH AB (SE) 2000-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020173519-A1 Quinoline derivatives CASP1, NFKBIA, IL1B HDAC4 1771/4885MEN1 1499/4885KMT2A 3692/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.